Open Access<p>Long‐term Risk of Malignant Neoplastic Disorders in Type 2 Diabetes Mellitus Patients with Metabolic Syndrome</p>
Author(s) -
Oana Albai,
Mirela Frandeș,
Bogdan Timar,
D Paun,
Deiana Roman,
Romulus Timar
Publication year - 2020
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s243263
Subject(s) - medicine , cancer , cohort , diabetes mellitus , gastroenterology , metabolic syndrome , population , type 2 diabetes mellitus , oncology , endocrinology , obesity , environmental health
In developing countries, cancer incidence has progressively increased, becoming the second cause of mortality after cardiovascular diseases. Type 2 diabetes mellitus (T2DM) is associated with an increased risk of malignant neoplastic disorders, especially pancreatic cancer, colorectal cancer, and breast cancer.